Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Kristian Reich(University of Göttingen), Frank O. Nestlé(University Hospital of Zurich), Kim Papp(Probity Medical Research), Jean‐Paul Ortonne(Hôpital l'Archet), Robert J. Evans, Cynthia Guzzo, Shu Li, Lisa T. Dooley, C.E.M. Griffiths(Salford Royal Hospital)
The Lancet
October 1, 2005
Cited by 1,042

Abstract


Related Papers

No related papers found

Powered by citation graph analysis